http://onthepharm.net/2006/05/high-cost-of-erbitux.html Life on the pharm Mon, 26 Jul 2010 18:29:42 +0000 hourly 1 http://wordpress.org/?v=3.0 http://onthepharm.net/2006/05/high-cost-of-erbitux.html/comment-page-1#comment-8910 Erbitux for first-line colon cancer treatment :: OnThePharm Wed, 10 Jan 2007 14:45:06 +0000 http://onthepharm.net/2006/05/high-cost-of-erbitux/#comment-8910 [...] Erbitux is still massively expensive. What remains to be seen is whether or not insurers will allow it as a first-line treatment. I’m inclined to think that they’ll insist on a “step therapy” regimen — at least into the near future. [...] [...] Erbitux is still massively expensive. What remains to be seen is whether or not insurers will allow it as a first-line treatment. I'm inclined to think that they'll insist on a "step therapy" regimen — at least into the near future. [...]

]]> http://onthepharm.net/2006/05/high-cost-of-erbitux.html/comment-page-1#comment-25 OnThePharm » “Pill Pushers” — science for salesmanship? Sun, 04 Jun 2006 03:10:10 +0000 http://onthepharm.net/2006/05/high-cost-of-erbitux/#comment-25 [...] Lifestyle drugs, like Viagra and Lamisil sell, and they sell well. They don’t save lives, but there’s nothing wrong with a drug that doesn’t save lives, implying that there is is totally ridiculous. Comparing Lamisil to Gleevec is absurd as well: drugs like Gleevec are already enormously expensive, and they catch lots of flak because they ARE expensive, by the same mainstream media that basically whines that they aren’t bigger sellers. [...] [...] Lifestyle drugs, like Viagra and Lamisil sell, and they sell well. They don't save lives, but there's nothing wrong with a drug that doesn't save lives, implying that there is is totally ridiculous. Comparing Lamisil to Gleevec is absurd as well: drugs like Gleevec are already enormously expensive, and they catch lots of flak because they ARE expensive, by the same mainstream media that basically whines that they aren't bigger sellers. [...]

]]> http://onthepharm.net/2006/05/high-cost-of-erbitux.html/comment-page-1#comment-12 OnThePharm » Avastin license applications and enrollment re-openings Thu, 25 May 2006 18:22:02 +0000 http://onthepharm.net/2006/05/high-cost-of-erbitux/#comment-12 [...] Of course if this is approved, it will only add fuel to the drug-pricing controversy. [...] [...] Of course if this is approved, it will only add fuel to the drug-pricing controversy. [...]

]]> http://onthepharm.net/2006/05/high-cost-of-erbitux.html/comment-page-1#comment-10 OnThePharm » Sumatriptan (Imitrex/Imigran) approved for OTC use in the UK Sat, 20 May 2006 16:11:54 +0000 http://onthepharm.net/2006/05/high-cost-of-erbitux/#comment-10 [...] In the United States when a drug goes OTC, you typically see a huge price drop because people are unwilling to pay what it actually cost their insurers when a drug is prescription-only. I’ve touched on this briefly in the past — people have no concept of the costs associated with medicine. You see medications go OTC like this when their patent protection is about to run out: mandatory generic substitution robs Big Pharma of revenues if a drug stays behind the counter. In the case of a relatively safe, proven drug like Imigran/Imitrex, making it available OTC can only mean more money for the manufacturer. People know the brand name, not the generic one, so that’s what they seek out. This is the same reason that Tylenol and Motrin outsell their generic counterparts. [...] [...] In the United States when a drug goes OTC, you typically see a huge price drop because people are unwilling to pay what it actually cost their insurers when a drug is prescription-only. I've touched on this briefly in the past — people have no concept of the costs associated with medicine. You see medications go OTC like this when their patent protection is about to run out: mandatory generic substitution robs Big Pharma of revenues if a drug stays behind the counter. In the case of a relatively safe, proven drug like Imigran/Imitrex, making it available OTC can only mean more money for the manufacturer. People know the brand name, not the generic one, so that's what they seek out. This is the same reason that Tylenol and Motrin outsell their generic counterparts. [...]

]]>